메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Nature Communications | Insilico Medicine Presents AI-empowered Dual-Action PROTAC Targeting PKMYT1

[ 메디채널 김갑성 기자 ] AI Designs a Novel RPOTAC from Scratch: Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, end-to-end approach to new modality drug discovery. A Superior Dual-Action Mechanism: The novel PROTAC, D16-M1P2, employs a powerful dual-action mechanism that simultaneously degrades and inhibits the cancer-driving PKMYT1 protein, resulting in a more potent, selective, and durable therapeutic effect than traditional inhibitors. Strong P
- 김갑성 기자
- 2025-12-02 22:00
Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities

SYDNEY, Dec. 2, 2025 -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity securities (PIPE). Pursuant to the securities purchase agreement, the Company agreed to offer and sell to the investors an aggregate of approximately $50.0 million of ordinary shares and prefunded warrants, at a purchase price per share that is the equivalent of $5.00 per ADS, each ADS representing 500 ordinary sh
- 김갑성 기자
- 2025-12-02 22:00
Frost & Sullivan: Health Recovery Solutions Receives the 2025 North American Customer Value Leadership Recognition for Excellence in Patient-Centered Care Delivery

[ 메디채널 김갑성 기자 ] Frost & Sullivan recognizes Health Recovery Solutions for delivering adaptable, outcomes-driven, technology-enabled longitudinal care models SAN ANTONIO, Dec. 2, 2025 -- Frost & Sullivan is pleased to announce that Health Recovery Solutions (HRS) has received the 2025 North American Customer Value Leadership Recognition in the longitudinal care models sector for its outstanding achievements in system efficiency, sustainable program outcomes, and long-term client value. This recognition highlights HRS's consistent leadership in delivering measurable improvement
- 김갑성 기자
- 2025-12-02 21:30
Global Fitness Leader Anytime Fitness Accelerates Asia Expansion with New Regional Agents for Taiwan

TAIPEI, Dec. 2, 2025 -- Anytime Fitness, the world's largest and fastest-growing fitness franchise, continues its momentum across Asia with significant new developments. With more than 5,600 clubs across 40 countries and on all seven continents, the brand remains unmatched in global presence and accessibility. In Asia, growth is driven by Inspire Brands Asia (IBA), the exclusive regional master franchisee for Singapore, Malaysia, Thailand, Taiwan region, the Philippines, Vietnam, Hong Kong SAR, and Indonesia. With a rapidly expanding network of over 520 clubs, the region is now
- 노기식 기자
- 2025-12-02 21:09
Health In Tech Announces Voluntary Extension of Lock-Up Period

STUART, Fla., Dec. 2, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and Board of Directors have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional six months beyond the original twelve-month lock-up established at the time of the Company's final prospectus issued in connection with its initial public offering on December 20, 2024. Under this voluntary extension, all shares hel
- 김갑성 기자
- 2025-12-02 21:00
HoneyNaps' AI Sleep-Diagnosis Software SOMNUM™ Selected as a 2025 Next Generation World Class Product at MOTIR Certification Ceremony

[ 메디채널 김갑성 기자 ] Recognized at the official 2025 World Class Product of Korea Certification Ceremony held at Lotte Hotel World, Seoul Certification affirms SOMNUM's potential to lead the global market within seven years HoneyNaps accelerates global expansion: "We aim to become Korea's leading SleepTech innovator" BOSTON, Dec. 2, 2025 -- HoneyNaps, an AI-based sleep-medicine company, announced that its AI PSG Auto-scoring software SOMNUM™ has been designated as a 2025 Next Generation World Class Product by Korea's Ministry of Trade, Industry, and Resources (MOTIR) and
- 김갑성 기자
- 2025-12-02 19:00
Neusoft Medical Systems Unveils World's First 8cm Wide-Coverage Photon-Counting CT and Other Premium Innovations at RSNA 2025

CHICAGO, Dec. 2, 2025 -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical"), a global leader in medical imaging, is showcasing its comprehensive portfolio of intelligent healthcare innovations at the Radiological Society of North America (RSNA) 2025 annual meeting. The highlight of the exhibition is the groundbreaking launch of the NeuViz P10, the world's first 8cm wide-coverage photon-counting CT. It is joined by several other high-end imaging systems and AI-integrated clinical solutions. The live demonstration presents a full-cycle intelligent imaging ecosystem s
- 김갑성 기자
- 2025-12-02 17:26
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy

SHANGHAI and HONG KONG, Dec. 2, 2025 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the China National Medical Products Administration (NMPA) has approved the investigational new drug (IND) application for the Phase Ib/II CLINCH-2 study evaluating ATG-022 (CLDN18.2 antibody-drug conjugate [ADC]) i
- 김갑성 기자
- 2025-12-02 17:00
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership

[ 메디채널 김갑성 기자 ] ZAGENO earns global recognition for driving innovation, operational efficiency, and transformative customer value across the life sciences e-commerce ecosystem. SAN ANTONIO, Dec. 2, 2025 -- Frost & Sullivan is pleased to announce that ZAGENO has been recognized with the 2025 Global Company of the Year Recognition in the life sciences e-commerce industry for its outstanding achievements in digital innovation, customer value enhancement, and strategic market execution. This recognition highlights ZAGENO's consistent leadership in driving measurable outcomes, strengt
- 김갑성 기자
- 2025-12-02 15:00
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health

∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 -- Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia® (Amgen), and Jubereq (denosumab), a biosimilar to Xgeva® (Amgen), following the scheduled expiry of the reference medicine's patent on 27 November 2025. Both medicines were approved by the European Medicines Agency (EMA) in September of this year following trials versus their reference product showing they are highly similar to the P
- 김갑성 기자
- 2025-12-02 15:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-12-19_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 19일 17시 00분